Clinical Trial Update: Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)

View source ↗

Summary

This clinical trial update describes a study evaluating fecal microbiota transplantation to reverse drug resistance in unresectable hepatocellular carcinoma. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Fujian Provincial Hospital | Conditions: Hepatocellular Carcinoma Non-resectable | Status: NOT_YET_RECRUITING